RE:RE:RE:RE:Growth by Aquisitionsunshine7 wrote: Select101 - What the HLL are you talking about. You speak nonsense so give it up. You don't know what is going on within ANY company until audited financials are released. Before that, you have guidance. If you honestly believe that MT would give guidance to guise a poor situation, then sell your shares or go short. Their lending is fixed and is unaffected by SP. As MT says - "its just noise". In fact, they have a large LOC that is undrawn! I am beginning to believe that you are also not telling the truth when you say you are long. Your posts are consistently negative, deceptive and non-sense.
select1011 wrote: You don't know that they have cash. I don't knew that they don't. I think we can both agree that they got lending on asset values, and those are now maybe cut in half?
Sunshine, I think we are wasting our time trying to educate select1011. Select1011, I can give you a scrip for Nefopam and in case u 'selectively' forgot what Nefopam does, it is all part of MT's master plan : Nefopam is the first generic to market in the United Kingdom in a drug class growing at approximately five per cent annually. According to IMS, the total non-narcotic painkiller market in the U.K. is approximately US$620 million annually. Nefopam is a non-narcotic analgesic that provides effective pain relief in many types of acute or chronic pain such as after surgery, dental pain, muscular pain (including after trauma) and pain associated with cancer..........WOW !!! First generic to market in the UK and a CXR product !!! There are many more wow's coming that you should educate yourself on so that you don't have to ask any more silly questions........GLTA.